JP2020505944A5 - - Google Patents

Download PDF

Info

Publication number
JP2020505944A5
JP2020505944A5 JP2019555724A JP2019555724A JP2020505944A5 JP 2020505944 A5 JP2020505944 A5 JP 2020505944A5 JP 2019555724 A JP2019555724 A JP 2019555724A JP 2019555724 A JP2019555724 A JP 2019555724A JP 2020505944 A5 JP2020505944 A5 JP 2020505944A5
Authority
JP
Japan
Prior art keywords
seq
protease variant
protease
amino acid
kumamoricin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019555724A
Other languages
English (en)
Japanese (ja)
Other versions
JP7035079B2 (ja
JP2020505944A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/084452 external-priority patent/WO2018115473A2/en
Publication of JP2020505944A publication Critical patent/JP2020505944A/ja
Publication of JP2020505944A5 publication Critical patent/JP2020505944A5/ja
Priority to JP2022031591A priority Critical patent/JP7344329B2/ja
Application granted granted Critical
Publication of JP7035079B2 publication Critical patent/JP7035079B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019555724A 2016-12-22 2017-12-22 安定なプロテアーゼ変異型 Active JP7035079B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022031591A JP7344329B2 (ja) 2016-12-22 2022-03-02 安定なプロテアーゼ変異型

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16206367.1 2016-12-22
EP16206367 2016-12-22
PCT/EP2017/084452 WO2018115473A2 (en) 2016-12-22 2017-12-22 Stable protease variants

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022031591A Division JP7344329B2 (ja) 2016-12-22 2022-03-02 安定なプロテアーゼ変異型

Publications (3)

Publication Number Publication Date
JP2020505944A JP2020505944A (ja) 2020-02-27
JP2020505944A5 true JP2020505944A5 (enExample) 2021-02-04
JP7035079B2 JP7035079B2 (ja) 2022-03-14

Family

ID=57629395

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019555724A Active JP7035079B2 (ja) 2016-12-22 2017-12-22 安定なプロテアーゼ変異型
JP2022031591A Active JP7344329B2 (ja) 2016-12-22 2022-03-02 安定なプロテアーゼ変異型

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022031591A Active JP7344329B2 (ja) 2016-12-22 2022-03-02 安定なプロテアーゼ変異型

Country Status (10)

Country Link
US (1) US11396648B2 (enExample)
EP (2) EP4732675A3 (enExample)
JP (2) JP7035079B2 (enExample)
KR (2) KR102553627B1 (enExample)
CN (1) CN110325636A (enExample)
AU (2) AU2017380106B2 (enExample)
BR (1) BR112019012980A2 (enExample)
CA (1) CA3047868A1 (enExample)
MX (2) MX2019007287A (enExample)
WO (1) WO2018115473A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020087017A1 (en) * 2018-10-26 2020-04-30 The Regents Of The University Of California Use of proteolytic enzymes to enhance protein bioavailability
US20250064903A1 (en) * 2020-10-30 2025-02-27 University Of Washington Compositions and methods for treating celiac sprue disease
JP7900846B2 (ja) 2022-01-26 2026-08-05 ダイジェスティーバ・インコーポレイテッド 血糖安定化方法及び組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1600141B1 (en) * 2004-05-24 2013-04-17 3M Deutschland GmbH Collagenolytic active enzyme containing compositions for the treatment of dental caries
LT2718434T (lt) * 2011-08-10 2018-08-10 University Of Washington Through Its Center For Commercialization Kompozicijos ir būdai, skirti celiakijos gydymui
US10266815B2 (en) * 2013-08-14 2019-04-23 University Of Washington Through Its Center For Commercialization Compositions and methods for treating celiac sprue disease
TN2017000520A1 (en) 2015-06-08 2019-04-12 Univ California Compositions and methods for treating celiac sprue disease
RS67180B1 (sr) 2016-06-23 2025-09-30 Ew Nutrition Gmbh Kompozicija za ishranu životinja koja sadrži kiselu proteazu

Similar Documents

Publication Publication Date Title
EP2470559A4 (en) COZY FACTORY IX COMPOSITIONS AND METHOD FOR THEIR PREPARATION AND USE
JP2013502226A5 (enExample)
JP2013530689A5 (enExample)
EP4491739A3 (en) Method for modifying the resistance profile of spinacia oleracea to downy mildew
MX358725B (es) Antigenos prostaticos de consenso, molecula de acido nucleico que los codifica y vacuna y usos que los comprenden.
WO2014118360A3 (en) Carbohydrate degrading polypeptide and uses thereof
JP2014500724A5 (enExample)
EA201991440A1 (ru) ТЕРМОСТАБИЛЬНЫЕ НУКЛЕАЗЫ Cas9
NZ603348A (en) Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
JP2021505201A5 (enExample)
MY160897A (en) Polypeptide having or assisting in carbohydrate material degrading activity and uses thereof
NZ604915A (en) Recombinant production of steviol glycosides
WO2011123830A3 (en) Alpha 1-antitrypsin compositions and methods of making and using same
JP2017507644A5 (enExample)
GB201201178D0 (en) Novel enzymes
MX2022006616A (es) Gen cca para la resistencia a los virus.
JP2018527030A5 (enExample)
CN102010869B (zh) 一种腊梅胚胎发育晚期丰富蛋白的基因及其抗低温应用
JP2017500888A5 (enExample)
BR112012010537A2 (pt) "clonagem, expressão e uso de fosfolipases ácidas"
MX2024000078A (es) Variantes de proteasas estables.
JP4264742B2 (ja) ラクトnビオースホスホリラーゼ遺伝子、該遺伝子を含む組換えベクター及び該ベクターを含む形質転換体
WO2010009465A3 (en) Htlv-ii vector and methods of use
JP2015156844A5 (enExample)
WO2018009050A8 (es) Factores de transcripción aislados de carica papaya y su aplicación para obtener plantas tolerantes a temperaturas extremas